Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2, Multi-Center, Randomized, Double-Blind, Vehicle-Controlled Clinical Study to Evaluate the Safety and Efficacy of 0.1% and 0.025% ASC-J9 Creams Applied Topically Twice Daily for 12 Weeks for the Treatment of Facial Acne Vulgaris

NCT01289574 is registered in ClinicalTrials.gov with AndroScience Corp as lead sponsor.

NCT NCT01289574
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01289574 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2, Multi-Center, Randomized, Double-Blind, Vehicle-Controlled Clinical Study to Evaluate the Safety and Efficacy of 0.1% and 0.025% ASC-J9 Creams Applied Topically Twice Daily for 12 Weeks for the Treatment of Facial Acne Vulgaris
Lead sponsor
AndroScience Corp
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2011
Completion date
August 31, 2012
Enrollment
181 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

acne